Literature DB >> 19574777

A comparison of perioperative morbidity, perioperative mortality, and disease-specific survival in elderly women (>or=70 years) versus younger women (<70 years) with endometrioid endometrial cancer.

Zvi Vaknin1, Ido Ben-Ami, David Schneider, Moty Pansky, Reuvit Halperin.   

Abstract

OBJECTIVE: The study compares the perioperative morbidity and mortality rates of elderly (>or=70 years) and younger (<70 years) patients with endometrioid endometrial cancer.
METHODS: The study cohort consisted of 115 consecutive women undergoing explorative laparotomy because of endometrioid endometrial cancer. Clinical data included patients' age, comorbidities, chronic use of medications, body mass index (kg/m), previous surgical procedures, surgical International Federation of Gynecology and Obstetrics stage, histological grade, relevant prognostic factors, a number of dissected lymph nodes, occurrence of perioperative complications, postoperative hospital stay (in days), and long-term disease-specific survival (in months).
RESULTS: Patients were divided into 2 groups: those younger than 70 years (group 1: 84 women, 73%) and those 70 years or older (group 2: 31 women, 27%). Although, as expected, elderly women had more major comorbidities, the rate of perioperative complications was similar between the 2 groups. In a logistic regression model, only chronic lung disease, gastrointestinal disease, and past abdominal surgery correlated with a higher rate of perioperative complications. None of the cohort patients died during the perioperative period. The long-term disease-specific survival was significantly poorer for the older group.
CONCLUSION: Chronological age by itself should not be a contraindication for the proper surgical treatment of elderly women with endometrioid endometrial cancer, because it is a poor predicting factor for perioperative morbidity and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19574777     DOI: 10.1111/IGC.0b013e3181a73a12

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium.

Authors:  P Mhawech-Fauceglia; R F Herrmann; J Kesterson; I Izevbaye; S Lele; K Odunsi
Journal:  Eur J Surg Oncol       Date:  2010-12       Impact factor: 4.424

2.  Feasibility study of pelvic helical IMRT for elderly patients with endometrial cancer.

Authors:  Jean-Emmanuel Bibault; Philippe Nickers; Emmanuelle Tresch; Abel Cordoba; Eric Leblanc; Pauline Comte; Thomas Lacornerie; Eric Lartigau
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

3.  Sentinel Lymph Node in Aged Endometrial Cancer Patients "The SAGE Study": A Multicenter Experience.

Authors:  Stefano Cianci; Andrea Rosati; Virginia Vargiu; Vito Andrea Capozzi; Giulio Sozzi; Alessandro Gioè; Salvatore Gueli Alletti; Alfredo Ercoli; Francesco Cosentino; Roberto Berretta; Vito Chiantera; Giovanni Scambia; Francesco Fanfani
Journal:  Front Oncol       Date:  2021-10-19       Impact factor: 6.244

Review 4.  Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer.

Authors:  Valentina Lancellotta; György Kovács; Luca Tagliaferri; Elisabetta Perrucci; Giuseppe Colloca; Vincenzo Valentini; Cynthia Aristei
Journal:  Biomed Res Int       Date:  2018-01-21       Impact factor: 3.411

Review 5.  Accuracy of preoperative sampling diagnosis for predicting final pathology in patients with endometrial carcinoma: a review.

Authors:  David Lukanović; Miha Matjašič; Borut Kobal
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.